Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04545697 · ClinicalTrials.gov registry record · NA
mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04545697 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 27 participants.
The verdict
NCT04545697, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Patients surviving with advanced prostate cancer frequently encounter time points in their disease course that require choosing among multiple options regarding systemic therapy. Interventions to improve shared decision-making through patient support measures such as question listing, and audio recording and summarizing of consultations have been shown to improve patient-reported measures of decision making quality, e.g. decreased decisional conflict and regret. However, the feasibility of consultation recording and summarizing with mobile health (mHealth) technology on patient-owned smartphones is unknown. The investigators will conduct a single-arm trial to determine feasibility and acceptability of a clinician-prompted, patient administered smartphone audio recording application and a service to summarize the recordings (Patient Support Corps or PSC), in improving decision-making quality among patients with chemotherapy-naive, progressive, metastatic castration-resistant prostate cancer (mCRPC). This trial will inform the design and conduct of a larger trial evaluating broader scale implementation of this intervention.
Interventions
- OTHER Medcorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04545697
The ClinicalTrials.gov registry entry for NCT04545697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medcorder is the first listed.
NCT04545697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04545697 about?
NCT04545697 is a clinical study titled "mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer". Patients surviving with advanced prostate cancer frequently encounter time points in their disease course that require choosing among multiple options regarding systemic therapy. Interventions to improve shared decision-making through patient support measures such as question listing, and audio reco...
What is the current status of trial NCT04545697?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2020-09-18. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT04545697?
The interventions under investigation include: Medcorder (OTHER).
Who is sponsoring clinical trial NCT04545697?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.